Kessler Investment Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16
| Closed | -$1.53K | – | 222 |
|
|
2024
Q4 | $1.53K | Sell |
16
-2
| -11% | -$191 | ﹤0.01% | 153 |
|
|
2024
Q3 | $1.82K | Sell |
18
-4,176
| -100% | -$423K | ﹤0.01% | 151 |
|
|
2024
Q2 | $389K | Buy |
+4,194
| New | +$389K | 0.21% | 60 |
|
|
2023
Q1 | – | Sell |
-14,027
| Closed | -$1.16M | – | 184 |
|
|
2022
Q4 | $1.16M | Sell |
14,027
-1,362
| -9% | -$113K | 1.23% | 22 |
|
|
2022
Q3 | $1.22M | Buy |
+15,389
| New | +$1.22M | 1.01% | 29 |
|
|
2021
Q4 | – | Sell |
-226
| Closed | -$29K | – | 192 |
|
|
2021
Q3 | $29K | Sell |
226
-8,436
| -97% | -$1.08M | 0.02% | 109 |
|
|
2021
Q2 | $1.17M | Buy |
8,662
+3,137
| +57% | +$425K | 0.93% | 34 |
|
|
2021
Q1 | $749K | Sell |
5,525
-37
| -0.7% | -$5.02K | 0.99% | 21 |
|
|
2020
Q4 | $783K | Buy |
5,562
+5
| +0.1% | +$704 | 0.84% | 27 |
|
|
2020
Q3 | $619K | Sell |
5,557
-3,124
| -36% | -$348K | 0.69% | 28 |
|
|
2020
Q2 | $972K | Buy |
+8,681
| New | +$972K | 1.18% | 27 |
|